Second Sight Medical Products announced market entry into Iran, implanting the first two patients with the company’s Argus II Retinal Prosthesis System. The implant was facilitated by the country’s exclusive distribution partner, Arshia Gostar Darman Co. Ltd.
“These first implants in Iran are part of our strategy to selectively target and partner with leading eye centers and distribution partners around the world in order to increase the availability of the Argus II to individuals with retinitis pigmentosa. The adoption of Argus II by a growing number of centers globally is a testament to the increasing acceptance of our technology,” Will McGuire, Chief Executive Officer of Second Sight, said in a company news release.
The implants were performed in Shiraz, Iran in November by Professor Mohsen Farvardin and his team at the Shiraz Pars Hospital and Khalili Hospital, Shiraz Medical Science University, in 44-year-old and 33-year-old patients with retinitis pigmentosa.
Professor Emin Özmert from the University Faculty of Medicine, Department of Ophthalmology, Ankara, Turkey acted as a supporting surgeon.